Patients with metastatic colon cancer respond to new combination therapy
Early but promising results lead to Phase II national trial
MD Anderson News Release 05/31/14
Poster # 3516
CHICAGO — In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan.
The Phase I trial, presented...
New software tool identifies genetic mutations that influence disease risk
Unique, robust method uses family data to find mutations for both common and rare diseases
MD Anderson News Release 05/30/14...
Women with metastatic breast cancer can safely receive bisphosphonates less frequently, without compromising care
Study findings could impact standard of care beyond breast cancer
MD Anderson News Release 05/30/14
Women with metastatic...
A Conversation With a Living Legend® raises more than $1 million
Former Secretary of State Condoleezza Rice takes stage with Fox News Channel’s Brit Hume
MD Anderson News Release 05/28/14
Dr. Condoleezza Rice was the honoree of The University of Texas MD Anderson Cancer Center’s A Conversation With a Living Legend®, Wednesday, May 21 at the Westin Galleria. Significantly surpassing all past years’ fundraising totals for the Houston event, it attracted 930 guests and raised more than...
Intensity Modulated Proton Therapy Shows Benefit for Head and Neck Cancer
Treatment completed without breaks, hospitalizations; results suggest proton therapy may be useful in management of head and neck tumors
Study identifies risk of chemotherapy related hospitalization for early-stage breast cancer patients
MD Anderson News Release 05/27/14
Oncologists now have a new understanding of the toxicity levels of specific chemotherapy regimens...
Scientists discover potential new target for cancer immunotherapy
Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells
MD Anderson News Release 05/25/14
...
Supportive tumor tissue surrounding cancer cells hinders, rather than helps, pancreatic cancer
Study shows fibrosis summons an immune attack, challenges theory that it blocks chemotherapy
MD Anderson News Release 05/22/14
UT MD Anderson tobacco-free hiring policy
MD Anderson News Release 05/20/14
In an effort to combat lung cancer and other serious diseases, The University of Texas MD Anderson...